Like so many of us, Beth Rubin, a Wall Street compliance director in her 50s, gained the Quarantine 10. “I wasn’t walking to the subway, the swimming pool in my building was closed, and my husband and I would split a bottle of wine every night. Everything was working against itself.” The problem, says Rubin, who lost 40 pounds 15 years ago and had, until lockdown, been able to keep it off, was that she was hungry all the time.
Then, in December, a miracle solution came in the form of a tiny needle. Rubin’s doctor, Katherine Saunders, an assistant professor of clinical medicine at Weill Cornell Medical College who specializes in medical strategies to counter obesity, put Rubin on Wegovy, a weekly injectable that was approved by the Food and Drug Administration in June 2021 to treat adults with obesity.
